M. v. M. Similon Et Al. , "Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs," EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60, pp.91-99, 2022
Similon, M. v. M. Et Al. 2022. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60 , 91-99.
Similon, M. v. M., Paasche, C., Krol, F., Lerer, B., Goodwin, G. M., Berk, M., ... Meyer-Lindenberg, A.(2022). Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60, 91-99.
Similon, AYŞEGÜL Et Al. "Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs," EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60, 91-99, 2022
Similon, AYŞEGÜL Y. Et Al. "Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs." EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60, pp.91-99, 2022
Similon, M. v. M. Et Al. (2022) . "Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs." EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol.60, pp.91-99.
@article{article, author={AYŞEGÜL YILDIZ YAVUZ Et Al. }, title={Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs}, journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY}, year=2022, pages={91-99} }